Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Sep 30;29(Suppl 2):S123–S130. doi: 10.3346/jkms.2014.29.S2.S123

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2014 The Korean Academy of Medical Sciences.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig. 3 — The relationship between the changes of 24-hr urine cytokines to creatinine ratio and urine sodium to creatinine ratio during 16 weeks after ARB medication. Frequency of increase in cytokine level: Frequency of increase in 24-hr urinary cytokine to creatinine ratio at 16-week compared to 0-week 25% or more. Increased 24HUna/cr defined as increase of 24HUna/cr ratio 25% or more, Decreased 24HUna/cr defined as decrease of 24HUna/cr ratio 25% or more, and unchanged 24HUna/cr defined as the ratio of 24HUna/cr between -24.9% and 24.9%, at 16-week compared to 0-week. uAGT/Cr: 24-hr urine angiotensinogen to creatinine ratio (pg/mg cr), uMCP1/Cr: 24-hr urine monocyte chemoattractant protein-1 to creatinine ratio (pg/mg cr), uMDA/Cr: 24-hr urine malondialdehyde to creatinine ratio (pM/mg cr).